Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
159 hedge funds and large institutions have $1.39B invested in Amedisys in 2016 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 50 reducing their positions, and 21 closing their positions.
186% more call options, than puts
Call options by funds: $2.36M | Put options by funds: $827K
96.84% more ownership
Funds ownership: 0% → 96.84% (+97%)
43% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 21
12% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 50
4% more funds holding
Funds holding: 153 → 159 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $1.47B → $1.39B (-$80.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$20.5M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$20.4M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$13.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.8M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$17M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$11.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$9.65M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$8.17M |
AMED Hedge Fund Activity: Q4 2016 in Review
159 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2016, worth a combined $1.39B — down 5.5% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new AMED positions and 21 closed out — a net gain of 9 holders — while 56 added to existing stakes and 50 trimmed.
The largest buyer was American Century Companies, opening a new position worth an estimated $20.5M. The largest seller was Vanguard Group, cutting an estimated $22.2M.
- 159 institutional investors held Amedisys (AMED) as of Q4 2016, up from 153 in Q3 2016.
- Funds reported $1.39B of Amedisys stock for Q4 2016, down 5.5% quarter-over-quarter.
- 30 funds opened new Amedisys positions in Q4 2016 and 21 closed out, a net change of +9 holders.
- The largest Amedisys buyer in Q4 2016 was American Century Companies, an estimated $20.5M added.
- The largest Amedisys seller in Q4 2016 was Vanguard Group, an estimated $22.2M sold.
Based on aggregated 13F filings for Q4 2016.